VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - March 29, 2006) - Allon Therapeutics Inc. (TSX:NPC), The Neuro Protection CompanyTM, reported today its 2005 audited operating results. The Company made significant progress in 2005 - and year-to-date in 2006 - toward achieving its goal to develop drugs that halt or prevent serious degenerative diseases and injury to the central nervous system.
